Best TWAS P=2.45e-13 · Best GWAS P=1.06e-11 conditioned to 0.806
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | ACTR1A | 0.03 | 0.01 | blup | 347 | 0.01 | 5.6e-02 | -4.0 | -5.2 | 2.3e-07 | 0.63 | 0.06 | 0.66 | FALSE |
2 | CommonMind | Brain Pre-frontal Cortex | AS3MT | 0.17 | 0.16 | lasso | 9 | 0.15 | 4.5e-18 | -4.1 | 5.2 | 2.1e-07 | -0.88 | 0.31 | 0.69 | FALSE |
3 | GTEx | Adipose Subcutaneous | CYP17A1-AS1 | 0.05 | 0.02 | enet | 10 | 0.03 | 2.8e-03 | -3.1 | -6.1 | 9.2e-10 | 0.65 | 0.08 | 0.78 | FALSE |
4 | GTEx | Artery Aorta | NT5C2 | 0.08 | 0.02 | lasso | 7 | 0.01 | 1.2e-01 | 2.9 | 5.3 | 1.2e-07 | -0.70 | 0.07 | 0.80 | FALSE |
5 | GTEx | Artery Tibial | NT5C2 | 0.06 | 0.04 | lasso | 9 | 0.02 | 1.5e-02 | -6.1 | 6.6 | 4.1e-11 | -0.92 | 0.04 | 0.89 | FALSE |
6 | GTEx | Artery Tibial | CYP17A1-AS1 | 0.08 | 0.08 | lasso | 8 | 0.06 | 2.8e-05 | -6.1 | -6.2 | 5.5e-10 | 0.89 | 0.07 | 0.92 | FALSE |
7 | GTEx | Brain Cerebellum | ARL3 | 0.20 | 0.09 | enet | 32 | 0.07 | 3.7e-03 | -6.5 | -6.7 | 2.6e-11 | 0.61 | 0.06 | 0.86 | FALSE |
8 | GTEx | Brain Cortex | CYP17A1-AS1 | 0.15 | 0.13 | lasso | 7 | 0.14 | 1.3e-04 | -6.5 | -6.8 | 1.3e-11 | 0.79 | 0.05 | 0.85 | FALSE |
9 | GTEx | Brain Hypothalamus | CYP17A1-AS1 | 0.34 | 0.10 | lasso | 10 | 0.05 | 2.6e-02 | -6.6 | -7.0 | 2.3e-12 | 0.69 | 0.04 | 0.71 | FALSE |
10 | GTEx | Brain Nucleus accumbens basal ganglia | CYP17A1-AS1 | 0.39 | 0.22 | lasso | 3 | 0.19 | 8.2e-06 | -6.5 | -6.4 | 1.7e-10 | 0.78 | 0.06 | 0.74 | FALSE |
11 | GTEx | Breast Mammary Tissue | CYP17A1-AS1 | 0.10 | -0.01 | enet | 28 | 0.00 | 2.4e-01 | -6.6 | -7.1 | 1.6e-12 | 0.67 | 0.06 | 0.68 | FALSE |
12 | GTEx | Breast Mammary Tissue (Male) | CYP17A1-AS1 | 0.06 | 0.00 | lasso | 3 | 0.01 | 2.1e-01 | 5.4 | -6.0 | 1.8e-09 | 0.42 | 0.04 | 0.07 | FALSE |
13 | GTEx | Breast Mammary Tissue (Female) | CYP17A1-AS1 | 0.14 | 0.01 | lasso | 11 | 0.00 | 4.7e-01 | -5.2 | -6.7 | 1.9e-11 | 0.64 | 0.05 | 0.34 | FALSE |
14 | GTEx | Cells EBV-transformed lymphocytes | ACTR1A | 0.22 | 0.18 | lasso | 3 | 0.19 | 8.0e-07 | 3.6 | -5.7 | 1.1e-08 | 0.56 | 0.30 | 0.47 | FALSE |
15 | GTEx | Cells EBV-transformed lymphocytes | RP11-18I14.11 | 0.17 | 0.08 | lasso | 8 | 0.09 | 8.7e-04 | 4.1 | -5.3 | 9.6e-08 | 0.34 | 0.20 | 0.16 | FALSE |
16 | GTEx | Liver | ACTR1A | 0.15 | 0.00 | lasso | 10 | 0.00 | 4.6e-01 | 1.5 | 5.8 | 6.3e-09 | -0.66 | 0.04 | 0.52 | FALSE |
17 | GTEx | Liver | TMEM180 | 0.28 | 0.17 | enet | 36 | 0.17 | 1.7e-05 | 4.2 | 5.7 | 9.5e-09 | -0.42 | 0.59 | 0.27 | FALSE |
18 | GTEx | Lung | CYP17A1-AS1 | 0.06 | 0.08 | lasso | 3 | 0.06 | 1.6e-05 | -6.5 | -6.7 | 2.3e-11 | 0.78 | 0.06 | 0.92 | FALSE |
19 | GTEx | Nerve Tibial | CYP17A1-AS1 | 0.14 | 0.08 | lasso | 6 | 0.06 | 7.2e-05 | -6.5 | -6.6 | 3.4e-11 | 0.77 | 0.07 | 0.88 | FALSE |
20 | GTEx | Pancreas | CYP17A1-AS1 | 0.11 | 0.06 | lasso | 5 | 0.06 | 1.1e-03 | -6.8 | -5.2 | 1.6e-07 | 0.85 | 0.03 | 0.80 | FALSE |
21 | GTEx | Testis | CYP17A1-AS1 | 0.14 | 0.08 | enet | 5 | 0.10 | 2.3e-05 | -5.1 | 5.1 | 2.8e-07 | -0.45 | 0.62 | 0.15 | FALSE |
22 | GTEx | Thyroid | SFXN2 | 0.28 | 0.06 | enet | 32 | 0.15 | 1.1e-11 | 1.8 | 5.4 | 7.3e-08 | -0.61 | 0.16 | 0.84 | FALSE |
23 | ROSMAP | Brain Pre-frontal Cortex | CNNM2 | 0.11 | 0.08 | lasso | 3 | 0.07 | 2.2e-09 | -5.2 | -5.2 | 2.6e-07 | 0.44 | 0.99 | 0.01 | FALSE |
24 | ROSMAP | Brain Pre-frontal Cortex | CYP17A1-AS1 | 0.15 | 0.18 | lasso | 6 | 0.19 | 1.3e-23 | -6.5 | -6.8 | 7.3e-12 | 0.77 | 0.07 | 0.93 | FALSE |
25 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | AS3MT | 0.06 | 0.09 | enet | 6 | 0.07 | 1.3e-06 | -6.8 | 7.3 | 2.5e-13 | -0.94 | 0.01 | 0.99 | TRUE |
26 | The Cancer Genome Atlas | Breast Invasive Carcinoma | AS3MT | 0.05 | 0.05 | enet | 10 | 0.05 | 4.7e-11 | -6.8 | 5.8 | 6.8e-09 | -0.94 | 0.00 | 1.00 | FALSE |
27 | The Cancer Genome Atlas | Breast Invasive Carcinoma | C10orf26 | 0.03 | 0.02 | enet | 5 | 0.02 | 1.6e-04 | 5.4 | 5.1 | 2.8e-07 | -0.31 | 0.87 | 0.05 | FALSE |
28 | The Cancer Genome Atlas | Glioblastoma Multiforme | AS3MT | 0.15 | 0.05 | blup | 62 | 0.10 | 5.1e-04 | -4.1 | 5.1 | 2.9e-07 | -0.87 | 0.02 | 0.81 | FALSE |
29 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | AS3MT | 0.05 | 0.05 | blup | 62 | 0.06 | 1.1e-07 | -6.1 | 5.4 | 8.4e-08 | -0.89 | 0.02 | 0.98 | FALSE |
30 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | AS3MT | 0.04 | 0.05 | enet | 3 | 0.04 | 8.6e-06 | -6.8 | 6.8 | 1.3e-11 | -1.00 | 0.00 | 0.99 | FALSE |
31 | The Cancer Genome Atlas | Brain Lower Grade Glioma | AS3MT | 0.34 | 0.38 | lasso | 6 | 0.38 | 4.4e-46 | -4.1 | 5.4 | 7.8e-08 | -0.92 | 0.32 | 0.68 | FALSE |
32 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | AS3MT | 0.13 | 0.14 | blup | 62 | 0.13 | 5.6e-06 | -6.1 | 6.1 | 1.1e-09 | -0.93 | 0.02 | 0.98 | FALSE |
33 | The Cancer Genome Atlas | Prostate Adenocarcinoma | AS3MT | 0.16 | 0.21 | lasso | 9 | 0.24 | 2.5e-24 | -6.8 | 5.7 | 1.5e-08 | -0.93 | 0.00 | 1.00 | FALSE |
34 | The Cancer Genome Atlas | Rectum Adenocarcinoma | C10orf32 | 0.17 | 0.14 | blup | 52 | 0.14 | 3.2e-04 | -6.1 | 6.6 | 5.5e-11 | -0.94 | 0.02 | 0.81 | FALSE |
35 | The Cancer Genome Atlas | Thyroid Carcinoma | AS3MT | 0.23 | 0.18 | lasso | 3 | 0.18 | 1.8e-17 | -6.8 | 6.5 | 6.5e-11 | -1.00 | 0.00 | 1.00 | FALSE |
36 | The Cancer Genome Atlas | Thyroid Carcinoma | C10orf26 | 0.06 | 0.05 | lasso | 5 | 0.04 | 4.1e-05 | -6.3 | 6.2 | 7.5e-10 | -0.68 | 0.06 | 0.91 | FALSE |
37 | The Cancer Genome Atlas | Thyroid Carcinoma | CYP17A1 | 0.04 | 0.02 | lasso | 1 | 0.02 | 3.9e-03 | -6.1 | 6.1 | 8.1e-10 | -0.85 | 0.02 | 0.75 | FALSE |